Metsera (MTSR) IPO deck
Metsera develops advanced therapies for obesity and metabolic diseases, leveraging cutting-edge peptide technologies.

Metsera develops advanced therapies for obesity and metabolic diseases, leveraging cutting-edge peptide technologies.